Every material Form 8-K BKV Corp has filed with the SEC since September 25, 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
BKV reported third-quarter 2026 results showing adjusted EBITDAX attributable to BKV of $132.7 million, up from $101.3 million a year earlier, and adjusted EPS of $0.36 versus $0.27. GAAP net income attributable to BKV fell to $29.4 million from $83.5 million, and the company also announced a cost reimbursement agreement covering up to approximately $179 million for expanded modular power development in Temple, Texas.
Net income attributable to BKV was $29.4 million, or $0.27 per diluted share, versus $83.5 million in the third quarter of 2025.
Adjusted EBITDAX attributable to BKV was $132.7 million, versus $101.3 million a year earlier; adjusted EPS was $0.36 versus $0.27.
A cost reimbursement agreement with a Leading Frontier AI Lab covers up to approximately $179 million if offtake arrangements are not agreed by November 18, 2026, with an aggregate cap of $374.1 million.
Fourth-quarter 2026 guidance calls for total capital expenditures of $315 million to $385 million and net production of 1,010 to 1,030 MMcfe/d.
BKV's subsidiary signed an equipment supply contract on October 2, 2026, for turbines and related equipment for a prospective Texas power project, at an aggregate price of about $800.0 million. The hyperscaler that backstops about 90% of near-term payments is also the intended offtaker, and BKV may terminate the contract without further payment obligations if offtake terms are not agreed by March 31, 2027.
Aggregate price of about $800.0 million, including $80.0 million in reservation fees previously paid that are credited against the price.
About $200.0 million is due on or before March 31, 2027, with about 90% of that covered by a backstop agreement with an investment-grade hyperscaler.
Equipment deliveries are scheduled between September 2028 and May 2029; BKV may terminate if offtake arrangements are not reached by March 31, 2027.
BKV's Board adopted an Executive Severance Plan on September 24, 2026, covering the company's named executive officers. The plan sets severance pay and benefits if a participant is terminated without cause or resigns for good reason, with larger payouts if this happens within two years after a change in control.
Plan adopted September 24, 2026, on the Compensation Committee's recommendation; initial participants include the named executive officers
Outside a change-in-control period, CEO receives 2.0 times base salary plus target bonus over 24 months; other participants receive 1.0 times over 12 months
Within two years after a change in control, CEO receives a lump sum of 3.0 times base salary plus target bonus; other participants receive 2.0 times
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every BKV Corp filing is on SEC EDGAR ↗. 8-K briefs of other companies →